Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc. | 15 | 9 | 1 | 2 | €30.40 | €41.51 | 36.554% |
| G1 Therapeutics | 19 | 2 | 3 | 1 | €2.07 | €10.54 | 409.836% |
| Novavax Inc. | 5 | 2 | 0 | 1 | €13.05 | €17.59 | 34.805% |
| Alnylam Pharmace. | 39 | 1 | 3 | 1 | €207.50 | €244.57 | 17.863% |
| Esperion Therapeutis.Inc. | 14 | 1 | 0 | 1 | €2.04 | €9.27 | 355.666% |
| Vertex Pharmaceuticals Inc. | 50 | 2 | 5 | 0 | €442.50 | €429.29 | -2.985% |
| Regeneron Pharmaceuticals Inc. | 41 | 1 | 5 | 0 | €990.80 | €1,025.4 | 3.487% |
| Merck & Co. Inc. | 32 | 1 | 4 | 0 | €124.00 | €125.34 | 1.079% |
| Pfizer Inc. | 30 | 4 | 3 | 0 | €26.41 | €40.66 | 53.955% |
| Abbott Laboratories | 18 | 0 | 1 | 0 | €98.06 | €116.48 | 18.785% |
| Johnson & Johnson | 38 | 1 | 6 | 0 | €138.90 | €187.15 | 34.739% |
| Eli Lilly Corp. | 60 | 0 | 12 | 0 | €829.40 | €824.11 | -0.638% |
| Amgen Inc. | 26 | 0 | 1 | 0 | €296.30 | €300.48 | 1.411% |
| Incyte Corp. | 12 | 2 | 0 | 0 | €59.38 | €78.05 | 31.436% |
| Biogen Inc. | 50 | 1 | 2 | 0 | €211.00 | €293.22 | 38.969% |
| AbbVie Inc. | 30 | 0 | 9 | 0 | €160.90 | €175.39 | 9.008% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €160.08 | €200.06 | 24.973% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.09 | €3.70 | 241.014% |
| Corcept Therapeutics Inc. | 14 | 0 | 3 | 0 | €28.50 | €37.08 | 30.098% |
| Rigel Pharmaceutical Inc. | 12 | 0 | 2 | 0 | €0.84 | €13.78 | 1543.292% |
| Gilead Sciences Inc | 13 | 1 | 2 | 0 | €65.88 | €83.21 | 26.298% |